SCHEMBL4617554

SCHEMBL4617554

CCCCCC(=O)CCCC(=O)O

nearest known ligand 0.91

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 2/20 0.91
MAPT P10636 2/20 0.91
AKR1B1 P15121 1/20 0.80
GPR84 Q9NQS5 7/20 0.76
PPARG P37231 7/20 0.76
PPARD Q03181 7/20 0.76
PPARA Q07869 7/20 0.76
HDAC11 Q96DB2 5/20 0.76
TSHR P16473 4/20 0.76
PTPN1 P18031 3/20 0.76
FABP4 P15090 3/20 0.76
ALDH1A1 P00352 2/20 0.76
TLR2 O60603 2/20 0.76
TDP1 Q9NUW8 2/20 0.76
ALOX15 P16050 2/20 0.76
HSD17B10 Q99714 2/20 0.76
SLC22A6 Q4U2R8 1/20 0.76
SLC22A8 Q8TCC7 1/20 0.76
MEN1 O00255 1/20 0.76
ESR1 P03372 1/20 0.76

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27960809 0.98 KMT2A (0.95) KMT2AMAPTAKR1B1GPR84PPARG
SCHEMBL27200215 0.98 KMT2A (0.95) KMT2AMAPTAKR1B1GPR84PPARG
SCHEMBL8509091 0.98 KMT2A (0.95) KMT2AMAPTAKR1B1GPR84PPARG
SCHEMBL7708163 0.98 KMT2A (0.95) KMT2AMAPTAKR1B1GPR84PPARG
SCHEMBL22033624 0.98 KMT2A (0.95) KMT2AMAPTAKR1B1GPR84PPARG
SCHEMBL19816013 0.98 KMT2A (0.95) KMT2AMAPTAKR1B1GPR84PPARG
SCHEMBL3185181 0.98 KMT2A (0.95) KMT2AMAPTAKR1B1GPR84PPARG
SCHEMBL7827913 0.98 KMT2A (0.95) KMT2AMAPTAKR1B1GPR84PPARG
SCHEMBL11066249 0.97 KMT2A (0.95) KMT2AMAPTAKR1B1GPR84PPARG
SCHEMBL26624798 0.95 KMT2A (0.91) KMT2AMAPTAKR1B1GPR84PPARG

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 143 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-113201511-B (R) -5-carbonyl decanoate (ester) reductase mutant and application thereof in preparation of (R) -gamma/delta-lactone 华东理工大学 2022-08-30 CN claimed
CN-114304142-A Trapping agent for trapping wasps, preparation method and preparation device thereof 生态环境部南京环境科学研究所 2022-04-12 CN claimed
CN-113816940-A Nicotine salts, co-crystals and salt co-crystal complexes R.J.雷诺兹烟草公司 2021-12-21 CN claimed
CN-113754634-A Nicotine salts, co-crystals and salt co-crystal complexes R.J.雷诺兹烟草公司 2021-12-07 CN claimed
CN-113201511-A (R) -5-carbonyl decanoate (ester) reductase mutant and application thereof in preparation of (R) -gamma/delta-lactone 华东理工大学 2021-08-03 CN claimed
CN-108323512-B Behavior control agent for Vespa spp 中国科学院西双版纳热带植物园 2021-04-20 CN claimed
CN-108323512-A Behaviour control agent and preparation method thereof for Vespa Vespa spp. drones 中国科学院西双版纳热带植物园 2018-07-27 CN claimed
CN-104651425-B A kind of method of living things catalysis synthesizing optical active al lactone 苏州百福安酶技术有限公司 2018-06-08 CN claimed
CN-106537149-A Method for screening trp channels 宝洁公司 2017-03-22 CN claimed
EP-3126831-A1 METHOD FOR SCREENING TRP CHANNELS The Procter & Gamble Company (US) 2017-02-08 EP claimed
WO-2015153184-A1 METHOD FOR SCREENING TRP CHANNELS THE PROCTER & GAMBLE COMPANY (US) 2015-10-08 WO claimed
US-20150272907-A1 Methods And Compositions For Modifying Sensorial Perception THE PROCTER & GAMBLE COMPANY 2015-10-01 US claimed
CN-104651425-A Method for biological catalyzed synthesis of optically active alkyl lactone SUZHOU BAIFU AN ENZYME TECHNOLOGY CO LTD 2015-05-27 CN claimed
CN-102010391-A Method for preparing high-purity delta decalactone SHANGHAI INST TECHNOLOGY 2011-04-13 CN claimed
US-5103047-A Process for preparation of 4- and 5-ketocarboxylic acids LORILLARD TOBACCO COMPANY (US) 1992-04-07 US claimed
US-20260107968-A1 END PLUG COMPRISING A SUBSTITUTED 3-(1-METHYLPYRROLIDIN-2-YL)PYRIDINE RAI STRATEGIC HOLDINGS INC (US) 2026-04-23 US disclosed
US-20260107969-A1 AEROSOL GENERATING MATERIAL COMPRISING A SUBSTITUTED 3-(1-METHYLPYRROLIDIN-2-YL)PYRIDINE COMPOUND RAI STRATEGIC HOLDINGS INC (US) 2026-04-23 US disclosed
WO-1998058899-A1 FRAGRANCE PRECURSOR COMPOUNDS GIVAUDAN-ROURE (INTERNATIONAL) S.A. (CH) 1998-12-30 WO disclosed
US-5103047-A Process for preparation of 4- and 5-ketocarboxylic acids LORILLARD TOBACCO COMPANY (US) 1992-04-07 US disclosed
EP-0410446-A1 (S)-5-hydroxydecanoic acid and its therapeutic composition MOCHIDA PHARMACEUTICAL CO., LTD. (JP) 1991-01-30 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260107968-A1 END PLUG COMPRISING A SUBSTITUTED 3-(1-METHYLPYRROLIDIN-2-YL)PYRIDINE ALK, EXOSC4, EXOSC9 KMT2A 3378/4885MAPT 4540/4885AKR1B1 3637/4885
US-20260107969-A1 AEROSOL GENERATING MATERIAL COMPRISING A SUBSTITUTED 3-(1-METHYLPYRROLIDIN-2-YL)PYRIDINE COMPOUND CHRM1, CHRM3, ATRIP KMT2A 1448/4885MAPT 1139/4885AKR1B1 2514/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.